Literature DB >> 10767597

Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells.

S Yamashita1, T Furubayashi, M Kataoka, T Sakane, H Sezaki, H Tokuda.   

Abstract

The effects of various experimental conditions on in vitro drug permeability to Caco-2 monolayers were investigated to determine the optimized conditions for the prediction of intestinal drug absorption. Concerning the pH of the transport medium in the Caco-2 study, two different pH values, 6.0 and 7.4, were tested for the apical medium with the pH of the basolateral medium fixed to 7.4. The change in the apical pH showed pronounced effects on the permeability of both passively and actively transported drugs. It was found that the transport study under the condition of an apical pH value of 6.0 showed a better prediction of in vivo drug absorption in human. The appropriate conditions for determining the permeability of poorly soluble drugs were also examined. First, the effects of bile acids, surfactant and some agents used for solubilizing drugs on the permeability and transepithelial electrical resistance (TEER) of Caco-2 monolayers were investigated. Taurocholic and cholic acid showed no effects on the permeability of 3H-Dexamethasone (DEX) and TEER at 10 mM concentration, suggesting the possibility of use in the Caco-2 study. Polyethyleneglycol-400 and dimethylsulfoxide reduced the permeability of DEX concentration dependently, whereas ethanol induced no significant changes in the permeability. Furthermore, it was demonstrated that the addition of plasma protein (bovine serum albumin) to the basolateral medium apparently facilitated the transport of poorly soluble drugs with high lipophilicity across Caco-2 monolayers. These findings clearly suggest the importance of considering the physiological conditions of in vivo drug absorption in optimizing the in vitro experimental conditions for transport study using Caco-2 cells, in order to obtain a satisfactory in vitro-in vivo correlation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10767597     DOI: 10.1016/s0928-0987(00)00076-2

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  72 in total

1.  Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs.

Authors:  Duxin Sun; Hans Lennernas; Lynda S Welage; Jeffery L Barnett; Christopher P Landowski; David Foster; David Fleisher; Kyung-Dall Lee; Gordon L Amidon
Journal:  Pharm Res       Date:  2002-10       Impact factor: 4.200

2.  Antileishmanial activity of imidothiocarbamates and imidoselenocarbamates.

Authors:  David Moreno; Daniel Plano; Ylenia Baquedano; Antonio Jiménez-Ruiz; Juan Antonio Palop; Carmen Sanmartín
Journal:  Parasitol Res       Date:  2010-10-05       Impact factor: 2.289

3.  Physicochemical properties and transport of steroids across Caco-2 cells.

Authors:  Fried Faassen; Jan Kelder; Johan Lenders; Rob Onderwater; Herman Vromans
Journal:  Pharm Res       Date:  2003-02       Impact factor: 4.200

4.  Development of a 7-day, 96-well Caco-2 permeability assay with high-throughput direct UV compound analysis.

Authors:  Jochem Alsenz; E Haenel
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

5.  Application of dissolution/permeation system for evaluation of formulation effect on oral absorption of poorly water-soluble drugs in drug development.

Authors:  Makoto Kataoka; Kiyohiko Sugano; Claudia da Costa Mathews; Jing Wen Wong; Kelly Lane Jones; Yoshie Masaoka; Shinji Sakuma; Shinji Yamashita
Journal:  Pharm Res       Date:  2011-12-02       Impact factor: 4.200

6.  In vitro-in situ permeability and dissolution of fexofenadine with kinetic modeling in the presence of sodium dodecyl sulfate.

Authors:  Evren Gundogdu; V Mangas-Sanjuan; Isabel Gonzalez-Alvarez; Marival Bermejo; Ercument Karasulu
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-08-11       Impact factor: 2.441

7.  To Apply Microdosing or Not? Recommendations to Single Out Compounds with Non-Linear Pharmacokinetics.

Authors:  Sieto Bosgra; Maria L H Vlaming; Wouter H J Vaes
Journal:  Clin Pharmacokinet       Date:  2016-01       Impact factor: 6.447

8.  Continuous Intestinal Absorption Model Based on the Convection-Diffusion Equation.

Authors:  Swati Nagar; Richard C Korzekwa; Ken Korzekwa
Journal:  Mol Pharm       Date:  2017-07-31       Impact factor: 4.939

9.  Exploration of 3,6-dihydroimidazo(4,5-d)pyrrolo(2,3-b)pyridin-2(1H)-one derivatives as JAK inhibitors using various in silico techniques.

Authors:  Radhakrishnan S Jisha; Lilly Aswathy; Vijay H Masand; Jayant M Gajbhiye; Indira G Shibi
Journal:  In Silico Pharmacol       Date:  2017-10-12

10.  In vitro plasma stability, permeability and solubility of mercaptoacetamide histone deacetylase inhibitors.

Authors:  Roula Konsoula; Mira Jung
Journal:  Int J Pharm       Date:  2008-05-13       Impact factor: 5.875

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.